Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Triomics raises $22M in Series B funding led by Battery Ventures to enhance its oncology-specific AI platform.
PRIVATEMay 27, 2026•2 months ago
Amount Raised
$22 Million
Round Type
Series B
San FranciscoInformation TechnologyInvestors
Y CombinatorLightspeedNexus Venture PartnersBattery Ventures
Description
Triomics has secured $22 million in Series B funding to advance its AI platform designed for oncologists and administrative staff. The funding round was led by Battery Ventures, with participation from Nexus Venture Partners, Lightspeed, and Y Combinator. The investment will help streamline data-heavy tasks in cancer care, improving efficiency for healthcare providers. This approach is crucial as oncology records become increasingly complex.
Related People
Suggested for you
2 contactsVerified contactsSarim T., Co-founder & CEO hidden hidden
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech